Sökning: id:"swepub:oai:DiVA.org:uu-187668" >
Integrated peripher...
Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients
-
- Radu, Calin, 1969- (författare)
- Uppsala universitet,Enheten för onkologi
-
- Norrlid, Ola (författare)
- Uppsala universitet,Enheten för onkologi
-
- Braendengen, Morten (författare)
- Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Oslo University Hospital, Oslo, Norway
-
visa fler...
-
- Hansson, Karl (författare)
- Karolinska Institutet
-
- Isacsson, Ulf (författare)
- Uppsala universitet,Enheten för onkologi
-
- Glimelius, Bengt (författare)
- Uppsala universitet,Enheten för onkologi
-
visa färre...
-
(creator_code:org_t)
- Informa Healthcare, 2013
- 2013
- Engelska.
-
Ingår i: Acta Oncologica. - : Informa Healthcare. - 0284-186X .- 1651-226X. ; 52:3, s. 528-537
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background and Purpose.Few studies have explored the potential clinical advantages of dose escalation and integrated boosts for patients with non-resectable locally advanced rectal cancer. The possibility of escalating dose to non-resectable regions in these patients was the aim of this study.Patients and methods.Seven patients with locally very advanced rectal tumours (sacrum overgrowth or growth into pelvic side walls) were evaluated. Intensity modulated photon and pencil beam scanning proton plans with simultaneously integrated boosts (45 Gy to elective lymph nodes, 50 Gy to tumour and 62.5 Gy to boost area in 25 fractions) were compared.Results.Target coverage was achieved with both photon and proton plans. Estimated risks of acute side effects put the two patients with the largest tumours at unacceptable risk for intestinal toxicity, regardless of modality. The remaining five patients had beneficial sparing of dose to the small intestine with protons.Conclusions.Adding boost to areas where rectal tumours infiltrate adjacent non-resectable organs is an attractive option which appears possible using both photon and proton irradiation. Proton plans reduced dose to organs at risk. Integrated peripheral boosts should be considered more frequently in these very advanced tumours.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
Nyckelord
- Oncology
- Onkologi
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas